These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 23353841)
1. Effects of cytochrome P450 inhibitors on peroxidase activity. Martinkova M; Kubickova B; Stiborova M Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841 [TBL] [Abstract][Full Text] [Related]
2. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices. Ly VT; Brock B Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958 [TBL] [Abstract][Full Text] [Related]
3. Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450. Aimová D; Stiborová M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):437-40. PubMed ID: 16601806 [TBL] [Abstract][Full Text] [Related]
4. Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation. Madan A; Parkinson A; Faiman MD Alcohol Clin Exp Res; 1998 Sep; 22(6):1212-9. PubMed ID: 9756035 [TBL] [Abstract][Full Text] [Related]
5. Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity. Naiman K; Martínková M; Schmeiser HH; Frei E; Stiborová M Mutat Res; 2011 Dec; 726(2):160-8. PubMed ID: 21946300 [TBL] [Abstract][Full Text] [Related]
6. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. Di Marco A; Yao D; Laufer R Eur J Biochem; 2003 Sep; 270(18):3768-77. PubMed ID: 12950260 [TBL] [Abstract][Full Text] [Related]
7. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes. Naiman K; Dracínská H; Martínková M; Sulc M; Dracínský M; Kejíková L; Hodek P; Hudecek J; Liberda J; Schmeiser HH; Frei E; Stiborová M Chem Res Toxicol; 2008 Aug; 21(8):1610-21. PubMed ID: 18624415 [TBL] [Abstract][Full Text] [Related]
8. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors. Kontijevskis A; Komorowski J; Wikberg JE J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition and inactivation of horseradish peroxidase by thiourea]. Ugarova NN; Popova IM; Dolmanova IF; Shekhovtsova TN Biokhimiia; 1981 Jun; 46(6):1026-34. PubMed ID: 6789896 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588 [TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Chauret N; Gauthier A; Martin J; Nicoll-Griffith DA Drug Metab Dispos; 1997 Oct; 25(10):1130-6. PubMed ID: 9321515 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of horseradish peroxidase inactivation by benzhydrazide: a critical evaluation of arylhydrazides as peroxidase inhibitors. Aitken SM; Ouellet M; Percival MD; English AM Biochem J; 2003 Nov; 375(Pt 3):613-21. PubMed ID: 12868961 [TBL] [Abstract][Full Text] [Related]
13. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine. Lakshmi VM; Zenser TV; Davis BB Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548 [TBL] [Abstract][Full Text] [Related]
14. Interaction of new sulfaphenazole derivatives with human liver cytochrome p450 2Cs: structural determinants required for selective recognition by CYP 2C9 and for inhibition of human CYP 2Cs. Ha-Duong NT; Marques-Soares C; Dijols S; Sari MA; Dansette PM; Mansuy D Arch Biochem Biophys; 2001 Oct; 394(2):189-200. PubMed ID: 11594733 [TBL] [Abstract][Full Text] [Related]
15. Application of micellar electrokinetic capillary chromatography for evaluation of inhibitory effects on cytochrome P450 reaction. Konecný J; Micíková I; Remínek R; Glatz Z J Chromatogr A; 2008 May; 1189(1-2):274-7. PubMed ID: 18036599 [TBL] [Abstract][Full Text] [Related]
16. Propyl gallate inhibition of iodide and tetramethylbenzidine oxidation catalyzed by human thyroid peroxidase. Grintsevich EE; Senchuk VV; Puchkaev AV; Metelitza DI Biochemistry (Mosc); 2000 Aug; 65(8):924-32. PubMed ID: 11002185 [TBL] [Abstract][Full Text] [Related]
17. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of cytochrome P450 suppress tumor necrosis factor production. Fantuzzi G; Cantoni L; Sironi M; Ghezzi P Cell Immunol; 1993 Sep; 150(2):417-24. PubMed ID: 8370080 [TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Ren S; Zeng J; Mei Y; Zhang JZ; Yan SF; Fei J; Chen L Drug Metab Dispos; 2013 Jan; 41(1):60-71. PubMed ID: 23033255 [TBL] [Abstract][Full Text] [Related]
20. N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo. Mathews JM; Bend JR J Pharmacol Exp Ther; 1993 Apr; 265(1):281-5. PubMed ID: 8474011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]